UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058827
Receipt number R000067271
Scientific Title Quantitative Evaluation of Intraocular Structures and Validation of Clinical Utility Using Next-Generation Swept-Source Optical Coherence Tomography
Date of disclosure of the study information 2025/08/31
Last modified on 2025/08/18 19:11:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Quantitative Evaluation of Intraocular Structures and Validation of Clinical Utility Using Next-Generation Swept-Source Optical Coherence Tomography

Acronym

Assessment of Intraocular Structures with Next-Generation SS-OCT

Scientific Title

Quantitative Evaluation of Intraocular Structures and Validation of Clinical Utility Using Next-Generation Swept-Source Optical Coherence Tomography

Scientific Title:Acronym

Assessment of Intraocular Structures with Next-Generation SS-OCT

Region

Japan


Condition

Condition

diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, rhegmatogenous retinal detachment, retinitis pigmentosa, glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate the clinical utility of next-generation swept-source optical coherence tomography (OCT) in assisting diagnosis and assessing disease severity of various ocular disorders, including age-related macular degeneration, diabetic retinopathy, and neovascular glaucoma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

retino-choroidal thickness

Key secondary outcomes

retinal vascular perfusion density


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

patients having an underlying ocular disorder

Key exclusion criteria

patients with poor fixation

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Shin
Middle name
Last name Kadomoto

Organization

Kyoto University

Division name

Ophthalmology

Zip code

606-8507

Address

Kyoto City Sakyo-Ku Shogo-in Kawara-Cho 54

TEL

075-751-3727

Email

kadomoto@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Shin
Middle name
Last name Kadomoto

Organization

Kyoto University

Division name

Ophthalmology

Zip code

606-8507

Address

Kyoto City Sakyo-Ku Shogo-in Kawara-Cho 54

TEL

080-3951-6021

Homepage URL


Email

kadomoto@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Kyoto University Ophthalmology Research Grant

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Kyoto City Sakyo-Ku Shogo-in Kawara-Cho 54

Tel

075-366-7618

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 08 Month 04 Day

Date of IRB


Anticipated trial start date

2025 Year 08 Month 31 Day

Last follow-up date

2026 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The device used in this study offers several improvements over conventional OCT systems, including higher imaging speed, enhanced spatial resolution, a wider scanning area, and greater acquisition stability, enabling more detailed visualization of retinal layer structures and the choroid. In addition, simultaneously acquired near-infrared reflectance images facilitate evaluation while allowing precise correlation between structural features and vascular localization.


Management information

Registered date

2025 Year 08 Month 18 Day

Last modified on

2025 Year 08 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067271